These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 20881231)

  • 21. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
    Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
    Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas.
    Kensler TW; Egner PA; Wang JB; Zhu YR; Zhang BC; Lu PX; Chen JG; Qian GS; Kuang SY; Jackson PE; Gange SJ; Jacobson LP; Muñoz A; Groopman JD
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S310-8. PubMed ID: 15508099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aflatoxin in maize: a review of the early literature from "moldy-corn toxicosis" to the genetics of aflatoxin accumulation resistance.
    Spencer Smith J; Paul Williams W; Windham GL
    Mycotoxin Res; 2019 May; 35(2):111-128. PubMed ID: 30729404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aflatoxin exposure in developing countries: the critical interface of agriculture and health.
    Wild CP
    Food Nutr Bull; 2007 Jun; 28(2 Suppl):S372-80. PubMed ID: 17658084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
    Groopman JD; Wang JS; Scholl P
    Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India.
    Anitha S; Raghunadharao D; Waliyar F; Sudini H; Parveen M; Rao R; Kumar PL
    Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():23-8. PubMed ID: 24657665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China.
    Chen JG; Egner PA; Ng D; Jacobson LP; Muñoz A; Zhu YR; Qian GS; Wu F; Yuan JM; Groopman JD; Kensler TW
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1038-45. PubMed ID: 23963804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between hepatitis B virus infection and exposure to aflatoxins in the development of hepatocellular carcinoma: a molecular epidemiological approach.
    Sylla A; Diallo MS; Castegnaro J; Wild CP
    Mutat Res; 1999 Jul; 428(1-2):187-96. PubMed ID: 10517992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aflatoxin Exposure During Pregnancy, Maternal Anemia, and Adverse Birth Outcomes.
    Smith LE; Prendergast AJ; Turner PC; Humphrey JH; Stoltzfus RJ
    Am J Trop Med Hyg; 2017 Apr; 96(4):770-776. PubMed ID: 28500823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycotoxins: occurrence, toxicology, and exposure assessment.
    Marin S; Ramos AJ; Cano-Sancho G; Sanchis V
    Food Chem Toxicol; 2013 Oct; 60():218-37. PubMed ID: 23907020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
    Wild CP; Montesano R
    Cancer Lett; 2009 Dec; 286(1):22-8. PubMed ID: 19345001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the Adverse Health Effects of Aflatoxin Exposure from Unpackaged Peanut Oil in Guangdong, China.
    He Z; Chen Z; Mo Y; Lu X; Luo Y; Lin S; Zhong Y; Deng J; Zheng S; Xia L; Wu H; Routledge MN; Hong Y; Xian X; Yang X; Gong Y
    Toxins (Basel); 2023 Nov; 15(11):. PubMed ID: 37999509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coping with the aflatoxin problem in the early years.
    Fischbach H
    J Assoc Off Anal Chem; 1984; 67(1):1-3. PubMed ID: 6365885
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of metabolism and viruses in aflatoxin-induced liver cancer.
    Groopman JD; Kensler TW
    Toxicol Appl Pharmacol; 2005 Aug; 206(2):131-7. PubMed ID: 15967201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biomarkers for aflatoxins and their application to human liver cancer.
    Scholl P; Musser SM; Kensler TW; Groopman JD
    Pharmacogenetics; 1995; 5 Spec No():S171-6. PubMed ID: 7581490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma: from gene to public health.
    Montesano R; Hainaut P; Wild CP
    J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aflatoxins and growth impairment: a review.
    Khlangwiset P; Shephard GS; Wu F
    Crit Rev Toxicol; 2011 Oct; 41(9):740-55. PubMed ID: 21711088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The aflatoxin problem: industry-FDA-USDA cooperation.
    Baur FJ; Parker WA
    J Assoc Off Anal Chem; 1984; 67(1):3-7. PubMed ID: 6365887
    [No Abstract]   [Full Text] [Related]  

  • 40. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.